Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.5.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19060.5South Korea
BT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.15 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.348NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.575NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.4 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.442NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.600NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.525 (Eta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.24 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.45 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.70 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.26.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.108 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.32 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.75.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.37 (Lambda)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.14 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used